Non-hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Non-hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-01-06Clinical Trial Update: WTX-330 in Patients With Advanced or Metastatic Solid Tumors or Non-Hodgkin Lymphoma [Phase 1]
Phase 1 trial of WTX-330 in patients with advanced or metastatic solid tumors or non-Hodgkin lymphoma has completed enrollment and posted re…
-
CLINICAL_TRIALS trial_result · 2026-01-06Clinical Trial Update: Immune Response After SARS-CoV-2 (COVID-19) Vaccination in a Context of Non-Hodgkin Lymphoma [NA]
This update summarizes immune responses to COVID-19 vaccination in patients with Non-Hodgkin lymphoma, with the trial status listed as termi…
-
CLINICAL_TRIALS research · 2026-01-06Clinical Trial Update: Study of CD30 CAR for Relapsed/Refractory CD30+ HL and CD30+ NHL [Phase 1, Phase 2]
Update on a CD30-targeted CAR-T cell therapy being studied for relapsed/refractory Hodgkin lymphoma and CD30+ Non-Hodgkin lymphoma in Phase …
-
CLINICAL_TRIALS research · 2026-01-06Clinical Trial Update: Clinical Study of Novel TLR2-Containing CAR-T Cells Targeting CD19 and CD22 for Relapsed/Refractory B-ALL and NHL [EARLY_Phase 1]
An early-phase Phase 1 study of a novel TLR2-containing CAR-T cell therapy targeting CD19 and CD22 for relapsed/refractory B-cell acute lymp…
-
CLINICAL_TRIALS trial_result · 2026-01-05Clinical Trial Update: Clinical Transplant-Related Long-term Outcomes of Alternative Donor Allogeneic Transplantation (BMT CTN 1702) [NA]
A completed clinical trial update reporting long-term outcomes of alternative donor allogeneic transplantation across multiple hematologic d…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-05Clinical Trial Update: Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN) [Phase 1]
Phase 1 trial evaluating activated T cells expressing second- or third-generation CD19-directed CAR-T cells in advanced B-cell malignancies.…
-
CLINICAL_TRIALS research · 2026-01-05Clinical Trial Update: The Feasibility and Clinical Efficacy of Atezolizumab Consolidation Treatment in High Risk (IPI > 2) DLBCL [Phase 2]
A phase 2 clinical trial is evaluating the feasibility and clinical efficacy of atezolizumab as consolidation therapy in high-risk diffuse l…
-
CLINICAL_TRIALS research · 2026-01-02Clinical Trial Update: PAX5-NEGATIVE HODGKIN-LIKE LYMPHOMAS: A DIAGNOSTIC CHALLANGE
A clinical trial update focusing on diagnosing PAX5-negative Hodgkin-like lymphomas, highlighting the diagnostic challenges in Hodgkin and n…
-
CLINICAL_TRIALS trial_result · 2025-12-31Clinical Trial Update: CAR-T Cell Therapy, Mosunetuzumab and Polatuzumab for Treatment of Refractory/Relapsed Aggressive Non-Hodgkin's Lymphoma (NHL). [Phase 2]
A Phase 2 clinical trial is evaluating a combination of CAR-T cell therapy with mosunetuzumab and polatuzumab for refractory/relapsed aggres…
-
CLINICAL_TRIALS research · 2025-12-31Clinical Trial Update: Clinical Study of LV009 Injection for the Treatment of Relapsed/Refractory CD19-Positive Hematologic and Lymphoid Malignancies [EARLY_Phase 1]
This clinical trial update describes an early-phase (Phase 1) study of LV009 injection for relapsed/refractory CD19-positive hematologic and…
-
CLINICAL_TRIALS research · 2025-12-29Clinical Trial Update: Radiation Dose Study for Relapsed/Refractory Hodgkin/Non-Hodgkin Lymphoma [NA]
An ongoing radiation dose study for relapsed/refractory Hodgkin lymphoma and non-Hodgkin lymphoma is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2025-12-29Clinical Trial Update: PET Imaging Study of 64Cu-GRIP B for Patients Receiving CD19-directed CAR-T Therapy [Phase 1]
A Phase 1 PET imaging study using the radiotracer 64Cu-GRIP B in patients receiving CD19-directed CAR-T therapy for non-Hodgkin lymphoma is …
-
CLINICAL_TRIALS trial_result · 2025-12-26Clinical Trial Update: A Study of LP-118 in Patients With Advanced Tumors [Phase 1]
Phase 1 study of LP-118 in patients with solid tumors and Non-Hodgkin lymphoma has reached completion.
-
CLINICAL_TRIALS trial_result · 2025-12-24Clinical Trial Update: Preliminary Safety and Tolerability of CD19x22 CAR T Cells in Adolescent and Adult R/R B-NHL Patients [Phase 1]
Phase 1 study assessing safety and tolerability of CD19x22 CAR T cells in adolescents and adults with relapsed/refractory B-cell non-Hodgkin…
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas. [Phase 1]
This is a Phase 1 dose-escalation and expansion study evaluating intratumoral ONM-501 alone and in combination with cemiplimab in patients w…
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma and Hodgkin's Disease
A Stanford University–sponsored clinical trial is recruiting to study clinical and pathologic aspects of Non-Hodgkin lymphoma and Hodgkin ly…
-
CLINICAL_TRIALS trial_result · 2025-12-23Clinical Trial Update: A Compassionate Use (CU) Program of Odronextamab
Compassionate-use program update for odronextamab in relapsed or refractory B-cell lymphomas, including follicular lymphoma and diffuse larg…
-
CLINICAL_TRIALS other · 2025-12-23Clinical Trial Update: Epcoritamab and Rituximab for First-line Follicular Lymphoma [Phase 2]
A Phase 2 clinical trial evaluating epcoritamab in combination with rituximab as first-line therapy for follicular lymphoma is currently rec…
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: A Study to Assess PK, Safety and Efficacy of HSK47977 Tablets in Subjects With Relapsed or Refractory Non-Hodgkin's Lymphoma [Phase 1]
This Phase 1 trial is evaluating pharmacokinetics, safety, and preliminary efficacy of HSK47977 tablets in adults with relapsed or refractor…
-
CLINICAL_TRIALS trial_result · 2025-12-18Clinical Trial Update: A Study of JNJ-64619178, an Inhibitor of PRMT5 in Participants With Advanced Solid Tumors, NHL, and Lower Risk MDS [Phase 1]
Phase 1 study of JNJ-64619178, a PRMT5 inhibitor, in participants with advanced solid tumors, Non-Hodgkin Lymphoma, and lower-risk myelodysp…
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: To Assess the Safety and Tolerability of Tafasitamab Alone or in Combination With Other Drugs in Japanese Participants With Non-Hodgkins Lymphoma (NHL) [Phase 1, Phase 2]
A Phase 1/2 clinical trial update assessing the safety and tolerability of tafasitamab alone or in combination with other drugs in Japanese …
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies [Phase 1, Phase 2]
A Phase 1/2 study is evaluating CCS1477 (Inobrodib) in multiple hematologic malignancies and is currently recruiting.
-
CLINICAL_TRIALS withdrawal · 2025-12-18Clinical Trial Update: A Study of CNTY-101 in Participants With CD19-Positive B-Cell Malignancies [Phase 1]
A Phase 1 study of CNTY-101 in CD19-positive B-cell malignancies has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-12-17Clinical Trial Update: Stem Cell Transplant With or Without Tbo-filgrastim in Treating Patients With Multiple Myeloma or Non-Hodgkin Lymphoma [Phase 2]
Phase 2 trial evaluated stem cell transplantation with or without the growth factor tbo-filgrastim in patients with multiple myeloma or non-…
-
CLINICAL_TRIALS trial_result · 2025-12-17Clinical Trial Update: Cytokine-Treated Veto Cells in Treating Patients With Hematologic Malignancies Following Stem Cell Transplant [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating cytokine-treated veto cells as an adoptive therapy after stem cell transplantation for various hematolog…